Spots Global Cancer Trial Database for Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
Official Title: An Observational Cohort Study on Transplant-Related Mortality in Patients Receiving Either a Hematopoietic Stem Cell Transplantation Without ATIR or an Umbilical Cord Blood Transplantation
Study ID: NCT02188290
Interventions
Study Description
Brief Summary: Study CR-AIR-006 is a part of the ATIR clinical development plan and will provide control data for patients treated with ATIR in clinical studies (e.g. study CR-AIR-007).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Algemeen Ziekenhuis Sint-Jan, Brugge, , Belgium
Institut Jules Bordet, Brussels, , Belgium
Universitair Ziekenhuis Gasthuisberg, Leuven, , Belgium
Hamilton Niagara Regional Haemophilia Centre, Hamilton, Ontario, Canada
Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
Universitätsklinikum Würzburg, Würzburg, , Germany
Academisch Ziekenhuis Maastricht, Maastricht, , Netherlands
Hammersmith Hospital, London, , United Kingdom
Contact Details
Name: Jeroen Rovers, MD
Affiliation: Kiadis Pharma
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
